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Introduction: Little is known about oxyhemoglobin (oxy-Hb) levels in the cerebral tissue during the development
of anoxic and ischemic brain injury. We hypothesized that the estimated cerebral oxy-Hb level, a product of Hb and
regional cerebral oxygen saturation (rSO2), determined at hospital arrival may reflect the level of neuroprotection in
patients with post-cardiac arrest syndrome (PCAS).
Methods: The Japan Prediction of neurological Outcomes in patients with Post cardiac arrest (J-POP) registry is a
prospective, multicenter, cohort study to test whether rSO2 predicts neurologic outcomes after out-of-hospital cardiac
arrest (OHCA). This study assessed a subgroup of consecutive patients who fulfilled the J-POP registry criteria and
successfully achieved return of spontaneous circulation (ROSC) from OHCA. The primary outcome measure was
the neurologic status at 90 days.
Results: We analyzed data from 495 consecutive comatose survivors who were successfully resuscitated from
OHCA, including 119 comatose patients with prehospital return of spontaneous circulation (ROSC; 24.0%) and
376 cardiac arrests at hospital arrival. In total, 75 patients (15.1%) presented with good neurologic outcomes.
Univariate analysis revealed that the cerebral oxy-Hb levels were significantly higher in patients with good outcomes.
Multivariate logistic regression using the backward-elimination method confirmed that the oxy-Hb level was a
significant predictor of good neurologic outcomes (adjusted odds ratio, 1.27; 95% confidence interval (CI),
1.11 to 1.46). Analysis of the area under the receiver operating characteristic curve (AUC) revealed that an oxy-Hb
cut-off of 5.5 provided optimal sensitivity and specificity for predicting good neurologic outcomes (AUC, 0.87; 95% CI,
0.83 to 0.91; sensitivity, 77.3%; specificity, 85.6%). The oxy-Hb level appeared to be an excellent prognostic indicator with
significant advantages over rSO2 and base excess, according to AUC analysis. The significant trend for good neurologic
outcomes was consistent, even in the subgroup of patients who achieved return of spontaneous circulation on hospital
arrival (1st quartile, 0; 2nd quartile, 16.7%; 3rd quartile, 29.4%; 4th quartile, 53.3%; P < 0.05).
Conclusions: The cerebral oxy-Hb level may predict neurologic outcomes and is a simple and excellent indicator of
neuroprotection in patients with PCAS.
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Although neurologic sequelae are common among survi-
vors of out-of-hospital cardiac arrest (OHCA), no early
prognostic markers have been reliably established [1-4].
The main objective of neurologic assessment of survivors
with post–cardiac arrest syndrome (PCAS) in the acute
postresuscitation period is not only to determine the on-
going injury but also to establish the patient’s recovery from
unresponsiveness [3]. Because the brain is highly suscep-
tible to ischemia, global cerebral ischemia often results in
neurologic impairment after OHCA, regardless of whether
a return of spontaneous circulation (ROSC) occurs [5,6].
Immediate high-quality cardiopulmonary resuscitation
(CPR) is crucial for optimal patient outcomes [7,8]. The
purpose of CPR is to provide effective oxygenation to
the vital organs, particularly the brain and heart, through
the artificial circulation of oxyhemoglobin (oxy-Hb) until
ROSC is achieved [7]. The intended effect is to stop the
processes of ischemia/anoxia caused by inadequate cir-
culation and oxygenation [9]. The restoration of blood
perfusion to the cerebral tissue and the capacity for oxy-
gen delivery are strongly associated with anoxic brain
damage during and after cardiac arrest. Notably, oxy-Hb
levels and cardiac output are essential determinants of
oxygen delivery during ongoing CPR attempts. However,
little is known about oxy-Hb levels in the cerebral tissue
during the development of anoxic and ischemic brain
injury.
Recently, cerebral oximetry with near-infrared spectros-
copy (NIRS) has been developed as a noninvasive technol-
ogy that may be used for monitoring cerebral oxygen
saturation during cardiac arrest [10-12]. Regional cerebral
oxygen saturation (rSO2) can be continually measured by
using the Beer–Lambert law [12,13], which describes
the ratio [oxy-Hb/(oxy-Hb + deoxyhemoglobin)] × 100
[14]. The estimated cerebral oxy-Hb level, which is the
product of blood hemoglobin (Hb) and rSO2, is described
as [Hb (g/dl) × rSO2 (%)]/100, and it can reflect the cere-
bral oxy-Hb level during and after resuscitation.
We hypothesized that the estimated cerebral oxy-Hb
level obtained on hospital arrival may reflect the level of
neuroprotection in patients who are successfully resusci-
tated after OHCA. This study aimed to determine whether
the estimated cerebral oxy-Hb level is a simple and effect-
ive predictor of 90-day neurologic outcomes in patients
with PCAS.
Materials and methods
Study design and settings
The Japan Prediction of neurological Outcomes in pa-
tients with Post cardiac arrest (J-POP) registry was a
prospective multicenter cohort study that was conducted
from May 15, 2011, to August 30, 2013, and involved 15
tertiary emergency hospitals.Patient selection
Patients included in the J-POP registry were unrespon-
sive during resuscitation on hospital arrival after OHCA.
To collect maximum clinical data from the real-world
setting, we included both comatose patients with de-
tectable pulses and those with sustained cardiac ar-
rest at arrival. Exclusion criteria were as follows: (a)
trauma, (b) accidental hypothermia, (3) age younger
than 18 years, (d) prior completion of a “Do Not At-
tempt Resuscitation” form, and (e) a Glasgow Coma
Scale score of >8 on hospital arrival. This study assessed
a subgroup of consecutive patients with OHCA who
fulfilled the J-POP registry criteria. In addition, we ex-
cluded those who were declared dead in the emergency
room, those not admitted to the hospital despite re-
ceiving advanced life support consistent with current
CPR guidelines, and those with Hb levels of <7.0 g/dl.
We collected only “post–cardiac arrest status” data for
the present study.Data collection
Data were prospectively collected with an Utstein-style
data form that included the following: age, sex, by-
stander–witness status, and presence and type of by-
stander CPR; origin of cardiac arrest, location of cardiac
arrest, and initial documented cardiac rhythm; advanced
airway management, use of epinephrine, or defibrillation
by emergency medical service (EMS) personnel; time
interval from EMS call to hospital arrival and ROSC be-
fore hospital arrival; administration of coronary angiog-
raphy, primary percutaneous coronary intervention, or
therapeutic hypothermia as a treatment after hospital
admission; and arterial pH, base excess, Hb levels, and
rSO2 on hospital arrival. Arterial pH, base excess, and
Hb levels were obtained within 10 minutes of hospital
arrival. Data management was performed by an independ-
ent data-coordinating center (Kyoto University Graduate
School of Medicine, Kyoto, Japan).EMS in Japan
Emergency services are provided 24 hours every day,
and the free emergency telephone number “119” is used
to call for an ambulance from anywhere in Japan. Most
ambulance crews have three EMS personnel, including
at least one emergency life-saving technician with ex-
tensive emergency care training. Emergency life-saving
technicians can insert adjunct airways, intravenous lines,
and can use semiautomated external defibrillators during
OHCA. All EMS personnel perform CPR according to
the 2010 Japanese CPR guidelines [9,15]. EMS personnel
are not permitted to terminate resuscitation in the
field; therefore, most OHCA patients are transported
to hospitals [16].
Figure 1 Patient selection.
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Immediately after hospital arrival, aiming within 3 minutes,
two disposable NIRS probes (INVOS 5100C; Covidien,
Boulder, CO, USA) were applied carefully and bilaterally
onto the patient’s forehead. rSO2 was stabilized over a
period of several seconds. The values were monitored for
at least 1 minute, and the lower of the two measured rSO2
values was adopted for analysis. The cerebral oximeter
emits 2 wavelengths of near-infrared rays (730 nm and
805 nm) into the patient’s forehead: it calculates spatial
depth resolution by subtracting the shallow from the deep
measurement, minimizes superficial signal contamination
from the scalp and skull, and detects changes in Hb satur-
ation in the brain [17,18]. The limits of detection for Hb–
oxygen saturation were <15% or >95% on the basis of a
cortical tissue depth of >2 cm [12]. This device inter-
prets a reading of 15% as equivalent to no detectable
cortical oxygen [12].
Study end points
The neurologic outcome was determined on the basis of as-
sessments at 90 days after hospital admission. The cerebral
performance category (CPC) score was used to categorize
neurologic outcomes as follows: CPC 1, good performance;
CPC 2, moderate disability; CPC 3, severe disability; CPC 4,
comatose or persistent vegetative state; and CPC 5, brain
death or death. Good neurologic recovery was defined as
CPC 1 and 2. CPC scores were further dichotomized into
good outcomes (CPC 1 or 2) and poor outcomes (CPC 3, 4,
or 5), which is an accepted categorization when evaluating
patients with PCAS. The primary end point was good
neurologic outcomes at 90 days after cardiac arrest [3].
Data analysis
Baseline characteristics were summarized in the two
groups defined by the primary end point (good or poor
neurologic outcomes). Multivariate logistic regression with
the backward-elimination method was used for adjusting
multiple selected covariates to assess the association be-
tween potential predictors and outcomes. Candidate vari-
ables were predefined by clinical importance [19] and from
the results of univariate analyses for the primary end point.
In general, approximately 10 or more events per variable
were accepted for multivariate modeling [20]. To evaluate
the potential predictors as prognostic tools, receiver oper-
ating characteristic (ROC) curve analyses were performed
for evaluating the accuracy in differentiating between good
and poor neurologic outcomes at 90 days. Nonparametric
estimates of the area under the ROC curves (AUCs) and
their 95% confidence intervals (CIs) were calculated.
Statistical analysis
Continuous variables were presented as mean ± standard de-
viation (SD) or median (25th or 75th percentiles), dependingon the distribution of the variables, and were compared by
using the Student t test (or analysis of variance) or Mann–
Whitney U test. Categoric variables were presented as
frequencies with percentages and were compared by
using the chi-square test or the Fisher Exact test. Bon-
ferroni correction was used to adjust for multiplicity.
Multiple logistic regression using the backward elimin-
ation method was used to assess factors associated
with 90-day good neurologic outcome. The Hosmer–
Lemeshow test was used to assess the goodness-of-fit
of multiple logistic regression models. AUCs between
two pairs of potential predictors were compared by
using a nonparametric test [21]. The linear trend in a
proportion across a factor was tested by means of the
exact Cochran–Armitage trend test. Significance levels
for all tests were two-sided and were set at P < 0.05.
All data were analyzed with SPSS version 19.0 (SPSS
Inc., Chicago, IL, USA) and SAS version 9.2 (SAS,
Cary, NC, USA).
Ethical considerations
Each participating center’s Institutional Review Board (IRB)
reviewed and approved the study (see Acknowledgements)
and waived the requirement for written informed consent




In total, 3,086 adult patients with OHCA were referred to
the participating emergency hospitals, 1,921 of which were
consecutively enrolled according to the inclusion criteria
of the J-POP registry. Subsequently, 1,382 patients who
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vanced life support, 26 patients for whom data regarding
demographic factors were lacking, and 18 patients with
Hb levels of <7.0 g/dl were excluded, and the data of the
remaining 495 patients were analyzed (Figure 1). The
demographic data are presented in Table 1. Of the 495 pa-
tients enrolled, 75 (15.2%) had a good outcome at 90 days
after cardiac arrest (CPC 1 = 57 and CPC 2 = 18). Among
the remaining 420 patients (84.8%) with a poor outcome,
8, 26, and 386 were diagnosed as CPC 3, CPC 4, and CPC
5, respectively. The 90-day mortality rate of all the enrolled




th, 75th percentiles), % b 19 (15,
Hemoglobin, mean (SD), g/dl b 12.1 (2.
Oxy-Hb, median (25th, 75th percentiles) b 2.3 (1.7
Age, mean (SD), years b 68 (16)
Male sex, n (%)a 330 (66
Location of cardiac arrest, n (%)b
Home 261 (52
Nursing home/Assisted living 48 (9.7)
Public building 43 (8.7)
Street 47 (9.5)
Others 96 (19.4
Bystander–witness status, n (%)b 344 (69
Type of bystander witness status, n (%)b
No witness 151 (30
Family member 177 (35
EMS 45 (9.1)
Others 122 (24
CPR initiated by bystander, n (%)b 199 (40
Presumed cardiac etiology, n (%)b 291 (58
Initial shockable rhythm, n (%)b 121 (24
Pre-hospital procedures by EMS personnel, n (%)
Advanced airway devicea 278 (56
Use of epinephrinea 155 (31
Defibrillationb 146 (29
Time from EMS call to hospital arrival, mean (SD), minb 34.7 (14
Achievement of ROSC prior to hospital arrival, n (%)b 119 (24
Treatment given after hospital arrival, n (%)
Coronary angiographyb 137 (27
Primary percutaneous coronary interventionb 57 (11.5
Therapeutic hypothermiab 187 (37
EMS, emergency medical service; Oxy-Hb, oxyhemoglobin; ROSC, return of spontan
poor-outcome group.Levels of rSO2, Hb, and estimated cerebral Oxy-Hb at
hospital arrival
The 495 patients had a median rSO2 value of 19% (15%
to 47%) and mean Hb levels of 12.1 ± 2.3 g/dl (Table 1).
The relation between the rSO2 value and Hb levels at
hospital arrival is shown in Figure 2. Including the pa-
tients who continued to receive CPR and arrived at hos-
pital immediately after ROSC, rSO2 was not correlated
with Hb levels (Spearman rank correlation coefficient: ρ =
0.12; P < 0.01). For all patients, the oxy-Hb level ranged
from 1.0 to 13.9, with a mean of 3.8 ± 2.8 and a median of




Outcome (n = 75)
Poor neurologic
Outcome (n = 420)
47) 61 (43, 65) 15 (15, 36)
3) 13.9 (2.1) 11.7 (2.2)
, 5.2) 8.3 (5.5, 9.7) 2.2 (1.7, 3.9)
59 (14) 69 (15)
.7) 58 (77.3) 272 (64.8)
.7) 27 (36.0) 234 (55.7)
4 (5.3) 44 (10.5)
14 (18.7) 29 (6.9)
12 (16.0) 35 (8.3)
) 18 (24.0) 78 (18.6)
.5) 67 (89.3) 277 (66.0)
.5) 8 (10.7) 143 (34.0)
.8) 27 (36.0) 150 (35.7)
8 (10.7) 37 (8.8)
.6) 32 (42.7) 90 (21.4)
.2) 47 (62.7) 152 (36.2)
.8) 64 (85.3) 227 (54.0)
.4) 43 (57.3) 78 (18.6)
.2) 25 (33.3) 253 (60.2)
.3) 13 (17.3) 142 (33.8)
.5) 50 (66.7) 96 (22.9)
.5) 30.3 (16.2) 35.5 (14.0)
.0) 55 (73.3) 64 (15.2)
.7) 53 (70.7) 84 (20.0)
) 20 (26.7) 37 (8.8)
.8) 56 (74.7) 131 (31.2)
eous circulation. aP < 0.05, bP < 0.001 between a good-outcome group and a
= 0.12, P< 0.01
rSO2 (%)
Figure 2 The relation between rSO2 and hemoglobin during resuscitation at hospital arrival. Oxy-Hb, estimated oxy-hemoglobin; rSO2,
regional cerebral oxygen saturation; ROSC, return of spontaneous circulation.
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The relation between the estimated oxy-Hb level and ar-
terial pH at hospital arrival is shown in Figure 3. The ar-
terial pH was significantly higher with higher oxy-Hb
quartiles [pH, 1st quartile of oxy-Hb: 6.88 (6.77, 7.02);
2nd quartile: 6.89 (6.77, 7.00); 3rd quartile: 6.97 (6.87,









Figure 3 The relation between estimated oxyhemoglobin levels and a
oxy-hemoglobin; rSO2, regional cerebral oxygen saturation; *P < 0.01, **P <Estimated Oxy-Hb levels as predictors of neurologic outcomes
in patients with PCAS
Univariate analyses revealed that the following potential
predictors were significantly associated with the pri-
mary outcome: Hb levels, rSO2, oxy-Hb levels, age,
sex, bystander–witness status, bystander CPR, presumed














rterial pH at hospital arrival. Hb, hemoglobin; Oxy-Hb, estimated
0.001.
Table 2 Multiple logistic regression model using
backward-elimination method, with good neurologic
outcome at 90 days as the dependent variable
Variable OR 95%CI
Oxy-Hb (per 1 increase) 1.27 1.11 to 1.46
ROSC before hospital arrival 6.78 2.66 to 17.28
Presumed cardiac etiology 2.93 1.14 to 7.56
Initial shockable rhythm 2.53 1.10 to 5.79
Bystander–witness status 2.29 1.14 to 4.59
Age 0.98 0.95 to 0.99
Therapeutic hypothermia 1.67 0.75 to 3.70
Time interval from EMS call to hospital arrival 0.98 0.95 to 1.00
Selected variables are a predefined set of potential confounders including age,
sex, initial shockable rhythm, bystander-witness status, CPR initiated by bystander,
ROSC before hospital arrival, presumed cardiac etiology,
time interval from EMS call to hospital arrival, therapeutic hypothermia, and
oxy-Hb. The Hosmer-Lemeshow tests.
were used to assess the goodness of fit of the model (P > 0.5).
EMS, emergency medical service; OR, odds ratio; Oxy-Hb, oxyhemoglobin;
ROSC, return of spontaneous circulation.
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lation by EMS personnel, time interval from EMS call to
hospital arrival, achievement of ROSC before hospital arrival,
administration of coronary angiography, primary percutan-
eous coronary intervention, and therapeutic hypothermia
(Table 1). A significant association was noted between oxy-
Hb levels and the primary outcome (unit odds ratio (OR):
1.60; 95% CI, 1.45 to 1.76; P < 0.001) after regression analysis.
The association between oxy-Hb levels and good neurologic
outcomes at 90 days is shown in Table 2 and Figure 4.
Multivariate analysis was adjusted for oxy-Hb, age, sex,
bystander–witness status, presumed cardiac etiology,




Figure 4 The relation between estimated oxy-Hb at hospital arrival and
Oxy-Hb, oxyhemoglobin.of ROSC before arrival at the hospital, time interval
from EMS call to hospital arrival, and administration
of therapeutic hypothermia. The results revealed that
the oxy-Hb level was a significant predictor of good
neurologic outcomes (adjusted unit OR, 1.27; 95% CI,
1.11 to 1.46; P < 0.001), such that a 1-unit increase in
oxy-Hb levels was associated with an approximate 30%
increase in the odds of a good neurologic outcome.
Even in the subgroup of patients without ROSC at hos-
pital arrival (n = 376; 20 patients with good neurologic
outcomes), the oxy-Hb level was significantly associ-
ated with an increase in good neurologic outcomes
(OR, 1.66; 95% CI, 1.30 to 2.12; multivariate logistic re-
gression using backward elimination; P < 0.001).
We also evaluated the sensitivity and specificity of dif-
ferent oxy-Hb, rSO2, Hb, and base excess cut-off values
among the entire cohort. ROC analysis revealed cut-offs
providing optimal sensitivity and specificity to predict
good neurologic outcomes at 90 days, which are summa-
rized in Table 3. In this cohort, oxy-Hb was the most reli-
able neurologic prognostic index, with significant advantages
over rSO2, Hb, and base excess (P < 0.001, Table 3 and
Figure 5).
Finally, we classified patients into four groups by oxy-
Hb and rSO2 quartiles to assess the relation between
these quartiles and the primary outcomes in the sub-
groups of patients with and without ROSC at hospital
arrival. In the subgroup of patients with sustained car-
diac arrest at hospital arrival, a significant trend was
found for a good neurologic outcome with increasing
oxy-Hb levels and rSO2 (Figure 6a). Of the 119 comatose
patients with ROSC at hospital arrival, 55 (46.2%) had
a good outcome at 90 days after cardiac arrest. Evencerebral performance category. CPC, cerebral performance category;
Table 3 Optimal cut-off value of oxy-Hb, rSO2, Hb, and base excess at hospital arrival for predicting a good neurologic
outcome at 90 days
Variables Optimal
cut-off




PPV NPV P value
(versus Oxy-Hb)
Oxy-Hb 5.5 0.87 (0.83 – 0.91) 77.3% (72.4 – 82.1) 85.0% (83.2 – 86.7) 47.9% 95.4% N/A
rSO2 40% 0.83 (0.78 – 0.88) 80.0% (75.3 – 84.6) 78.6% (76.5 – 80.6) 40.0% 95.6% < 0.001
Hb 13.0 g/dl 0.77 (0.70 – 0.81) 73.3% (68.1 – 78.4) 70.2% (69.7 – 72.4) 30.5% 93.6% < 0.001
Base excess −18.7 mM 0.68 (0.63 – 0.74) 96.0% (93.7 – 98.2) 37.4% (35.0 – 39.7) 21.4% 98.1% < 0.001
AUC, area under the curve; CI, confidence interval; Hb, hemoglobin, NPV, negative predictive value; Oxy-Hb, oxyhemoglobin; PPV, positive predictive value; rSO2,
regional cerebral oxygen saturation.
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neurologic outcomes across increasing oxy-Hb quar-
tiles (1st quartile, 0; 2nd quartile, 16.7%; 3rd quartile,
29.4%; 4th quartile, 53.3%; Cochran–Armitage trend
test, P < 0.05) but not across rSO2 quartiles (12.5%, 0;
50.0%, and 48.4%, respectively; P = 0.14) (Figure 6b).
In this subgroup, AUC to predict good neurologic
outcomes at 90 days for oxy-Hb (AUC, 0.67; 95% CI,
0.58 to 0.77; P = 0.001) was superior to that for rSO2
(AUC, 0.56; 95% CI, 0.45 to 0.66; P > 0.05).
Discussion
In this study, the estimated cerebral oxy-Hb level on
hospital arrival was a valid indicator of 90-day neuro-
logic outcome in patients who successfully achieved
ROSC from OHCA. The estimated oxy-Hb level was easily
and immediately obtained on hospital arrival. We verified
the hypothesis that oxy-Hb is associated with neuroprotec-
tion in patients with PCAS on the basis of the theoret-
ical assumption that the product of Hb and rSO2 may




Figure 5 AUC of each potential indicator for predicting
neurologic outcome at 90 days. The area under the receiver
operating characteristic curve (AUC) of each potential indicator to
predict good neurologic outcome at 90-day hospital admission in
patients with post–cardiac arrest syndrome. *P < 0.001 versus AUC
of oxyhemoglobin.revealed that the oxy-Hb value was a significant predictor
of good neurologic outcomes in the entire cohort. AUC
was significantly greater for oxy-Hb than for rSO2, Hb,
and base excess, which were independently shown to be
associated with neurologic outcomes [23,24]. Moreover,
our results revealed that the oxy-Hb level determined in
the immediate post-ROSC period could reflect the severity
of neuroprotection, even in a subgroup of patients with
ROSC before hospital arrival.
In a previous prospective multicenter cohort study, it
was reported that, on the basis of specificity, positive
predictive value, and AUC, rSO2 of >42% at hospital ar-
rival was an excellent neurologic prognostic index in
OHCA (including patients who received ongoing CPR)
and that rSO2 also had advantages over base excess [25].
In the present subgroup of patients who successfully
achieved ROSC from OHCA, both rSO2 and oxy-Hb
levels were strong predictors of neurologic outcomes,
which was consistent with the results of the previous
study [25]. However, our study revealed that it was diffi-
cult to predict neurologic outcomes with rSO2 alone if
patients had already achieved ROSC before hospital ar-
rival (Figure 6a). This is probably because cerebral oxim-
etry typically increases after ROSC [12]. Although it has
been shown that hyperoxia is associated with adverse
outcomes after resuscitation [26], supporting the con-
cept that supranormal arterial oxygen tension over the
first 24-hour period in the intensive care unit (ICU)
could be harmful to humans [26], our data suggest that
increased circulating oxy-Hb in brain tissue may be cru-
cial for neuroprotection during CPR.
A meta-analysis by Sasson et al. [19] indicated that
ROSC in the field is the most powerful factor associated
with survival from OHCA, which was consistent with
our results (Table 2). Therefore, surrogates of neuro-
protection are required in patients with pre-hospital
ROSC. Our results indicated that increasing oxy-Hb
levels reflected progressively superior neurologic out-
comes, even in patients in the immediate post-ROSC
period (Figure 6b).
Tissue metabolism and cerebral oxy-Hb depend on a
balance between oxygen consumption, blood Hb levels,
(n=376)
(n=119)
Figure 6 The association between rSO2 and estimated cerebral oxy-hemoglobin and frequency of good neurologic outcomes. Study
participants were divided into four groups by oxy-Hb and rSO2 quartiles (Q1, n = 126; Q2, n = 122; Q3, n = 124; Q4, n = 123 for oxy-Hb: Q1, n = 221;
Q2, n = 28; Q3, n = 125; Q4, n = 121 for rSO2). (a) Subgroup of patients with sustained cardiac arrest at hospital arrival (n = 376). (b) Subgroup of patients
with ROSC at hospital arrival (n = 119). Oxy-Hb, estimated oxyhemoglobin; rSO2, regional cerebral oxygen saturation; ROSC, return of spontaneous
circulation.
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bral perfusion and subsequently reduced cerebral NIRS
and oxy-Hb readings during CPR or after ROSC are most
likely caused by low cardiac output. However, the differen-
tial diagnosis for the low cerebral NIRS readings also in-
cludes intracranial hematomas [27], low arterial oxygen
saturation [28], and isolated cerebral circulatory arrest
[29,30]. Although blood Hb levels theoretically play a cru-
cial role in maintaining tissue metabolism, this has not yet
been sufficiently studied during CPR. To resolve the tissue
oxygen debt during cardiac arrest, blood circulation must
be secured by high-quality and less-interrupted chest
compressions [7]. In our study, a significant relation was
found between oxy-Hb levels and arterial pH, suggesting
that increasing oxy-Hb levels during CPR may attenuate
metabolic acidosis by appropriate chest compression. Be-
cause rSO2 may reflect the balance between oxygen deliv-
ery and regional (frontal) cerebral metabolism, the product
of blood Hb levels and cerebral oxygen saturation could
parallel oxygen delivery during resuscitation. Therefore,
rSO2 measured during CPR attempts could indicate
whether the ongoing attempt is likely to sustain ad-
equate oxygen delivery to cerebral tissues [31].
The clinical experience of cardiac-arrest resuscitation
demonstrates that circulatory recovery does not always coin-
cide with cerebral recovery. The high morbidity of neuro-
logic dysfunction in patients with ROSC after OHCA has
led to several clinical studies attempting to optimize neuro-
logic outcomes through therapeutic efforts that include
targeted temperature management or administration ofneuroprotective medications [32-34]. Our data are con-
sistent with this clinical experience: although a standard
CPR method may deliver adequate coronary perfusion to
reverse cardiac arrest, it may deliver inadequate oxy-Hb to
the central nervous system and contribute to cellular
damage in cerebral tissue.
The ability to predict outcomes early is an important as-
pect of postresuscitation care in patients with PCAS. A
multimodal prediction approach has been evaluated for
outcome prognostication after cardiac arrest and thera-
peutic hypothermia [35]. This incorporates neurologic
examination [36,37], electroencephalography [37,38], som-
atosensory evoked potentials [39,40], neuron-specific eno-
lase [41,42], and magnetic resonance imaging [43-45].
Multimodal scores that combine both clinical and labora-
tory variables have also been developed for outcome pre-
diction. The OHCA score presented by Adrie et al. [46]
predicts good neurologic outcomes for patients with AUC
of 0.79 in a heterogeneous population of successfully re-
suscitated adult patients with OHCA. The advantage of
prognostication using oxy-Hb is that prognostic assessment
can be readily performed at hospital arrival. Moreover,
modern multimodal severity-scale scores predict survival
with an AUC of approximately ≥0.80 after further con-
founders are included [47,48], whereas oxy-Hb at hospital
arrival has an AUC of 0.87. Thus, oxy-Hb has real potential
as an indicator of neuroprotection in patients with PCAS.
Recently, Nielsen et al. [49] described that therapeutic
hypothermia at a target temperature of 33°C conferred
no additional benefit compared with that at a targeted
Hayashida et al. Critical Care 2014, 18:500 Page 9 of 11
http://ccforum.com/content/18/5/500temperature of 36°C. One of several explanations for
this absence of benefit is that illness severity varies
greatly, and appropriate subgroups of patients may bene-
fit from induced hypothermia. In particular, when the de-
gree or duration of hypothermia must be adjusted to
match injury severity, the benefits to a subgroup may be
masked if appropriate subgroups are not defined [50].
Our results provide the possibility for estimated cerebral
oxy-Hb levels to define subgroups that may benefit from in-
dividual therapies and to clarify how to adjust temperature
targets to particular severities.
This study had several limitations. First, blind moni-
toring of rSO2 was not conducted because it requires
real-time visual confirmation during CPR efforts; this
did not affect day-to-day patient care. Second, because
of the overall mortality of 78.0%, the small cohort, and
the fact that only 75 patients had good neurologic out-
comes, future research with more patients is essential to
validate our findings. Third, patients with significant
anemia at the time of enrollment (Hb < 7.0 g/dl) were
excluded from the present study; thus, our data are ap-
plicable only to patients with modest Hb reductions.
Fourth, we were unable to control for blood bilirubin
concentration in this study, and given that bilirubin is
known to influence NIRS [51,52], it may have influenced
the readings. Finally, rSO2 was measured only at a single
measurement point in this study. We recognized the im-
portance of understanding the impact of time on changes
in rSO2 for the prognostication of neurologic outcomes.
Thus, we are presently collecting rSO2 data regularly dur-
ing admission to the ICU. Furthermore, neither the rela-
tion between rSO2 and Hb levels over time nor the
clinical effect of red blood cell transfusion on outcomes is
clear. Thus, although the results of this study are promis-
ing, they remain inconclusive on whether to continue or
withdraw care for patients with PCAS.
Conclusions
In summary, our data provide evidence that the esti-
mated oxy-Hb level may help to predict favorable 90-day
neurologic outcomes in patients with PCAS. Further-
more, our study demonstrated that the oxy-Hb level de-
termined immediately on hospital arrival was significantly
higher in patients with good outcomes (AUC= 0.87), mak-
ing it a simple and effective indicator of neuroprotection in
patients with PCAS. Thus, the estimated oxy-Hb level may
be included as part of a multimodal package for prognosti-
cation after cardiac arrest and warrants larger-scale studies.
Key messages
 The ability to predict outcomes early is an
important aspect of postresuscitation care in
patients with PCAS. Cerebral oximetry with NIRS has been developed as
a noninvasive technology that may be used for
monitoring cerebral oxygen saturation during
cardiac arrest.
 Oxy-Hb levels and cardiac output are essential
determinants of oxygen delivery during ongoing
CPR attempts.
 The estimated oxy-Hb level obtained on hospital arrival
may help to predict favorable 90-day neurologic
outcomes in patients who are successfully resuscitated
after OHCA.
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